IBSA will attend the OARSI Congress (http://2011.oarsi.org) with a Satellite Symposium (Pdf) scheduled on Friday, September 16th, from 12.00 to 13.30 (Hilton Bayfront Hotel, Sapphire Room). The symposium will be the occasion to further highlight the pharmacology and the benefit/risk profile of intra-articular hyaluronic acid in the management of knee OA and, above all, to present the new available clinical data on Sinovial/Intragel.


IBSA will attend the ETA Congress (www.eta2011.com) with a Satellite Symposium (Pdf) scheduled on Monday, September 12th, from 13.00 to 14.00 (Aula Duza - Main Hall, Auditorium Maximum of the Jagiellonian University). The event will be the occasion to present the latest developments on the levothyroxine soft gel capsules (Tirosint®), it will provide an opportunity to hear expert endocrinologists cover pressing clinical issues in the management of hypothyroidism with this new LT4 formulation developed by IBSA.